We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Tenon Medical Inc | NASDAQ:TNON | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.71 | 2.71 | 2.80 | 1,105 | 09:48:34 |
Tenon Medical, Inc.
104 Cooper Court
Los Gatos, CA 95032
February 15, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Benjamin Richie
Re: Tenon Medical, Inc. Withdrawal of Acceleration Request
Registration Statement on Form S-1, as amended
File No. 333-269653
Ladies and Gentlemen:
On February 8, 2023, Tenon Medical, Inc. (the “Company”), initially filed a Registration Statement on Form S-1 (File No. 333-269653) (together with the exhibits and amendments thereto, the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “Commission”).
Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the Commission consent to the withdrawal of the Registration Statement effective as of the date hereof. The Company is seeking withdrawal of the Registration Statement because it no longer wishes to conduct a public offering of its securities at this time. The Registration Statement has not been declared effective by the Commission and no securities have been issued or sold under the Registration Statement. Based on the foregoing, the Company submits that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by Rule 477(a).
The Company acknowledges that no refund will be made for fees paid to the Commission in connection with the filing of the Registration Statement. However, in accordance with Rule 457(p) under the Securities Act, the Company requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.
Please direct any questions or comments regarding this correspondence to our counsel, Carmel, Milazzo & Feil LLP, by calling Jeffrey Wofford at 212-658-0458 or email at jwofford@cmfllp.com.
Thank you for your assistance in this matter.
Very truly yours, | ||
By: | /s/ Steven M. Foster | |
Name: | Steven M. Foster | |
Title: | Chief Executive Officer |
cc: Jeffrey Wofford, Carmel, Milazzo & Feil LLP
1 Year Tenon Medical Chart |
1 Month Tenon Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions